{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:54:21Z","timestamp":1785678861516,"version":"3.56.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>The separation of malignant mesothelioma from non\u2013small cell lung carcinomas can be a difficult problem. Sex-determining region Y box 6 (SOX6) and disabled homolog 2 (DAB2) have recently been proposed as sensitive\/specific markers of mesothelial lineage, but have not yet been independently tested for utility in mesothelioma diagnosis. Using tissue microarrays containing mesotheliomas (epithelioid: n=40, sarcomatoid: n=23) and non\u2013small cell lung carcinomas (adenocarcinoma: n=52, squamous cell carcinoma: n=57, large cell carcinoma: n=12) we evaluated the performance of SOX6 and DAB2 by themselves, in conjunction with other established mesothelioma markers (calretinin, WT1, D2-40, CK5\/6, HEG1) and combined with 3 broad-spectrum established carcinoma markers: claudin-4, MOC31, and BerEP4. For epithelioid mesothelioma, SOX6 and DAB2 had sensitivities of 85% and 98%, respectively. For sarcomatoid mesothelioma, SOX6 had a sensitivity of 13% and DAB2 could not be assessed due to background stromal staining. For SOX6 alone, specificity for mesothelioma versus adenocarcinoma, squamous cell carcinoma, and large cell carcinoma was 94%, 79%, and 92%, respectively, while for DAB2 specificity was 77%, 86%, and 67%. Combinations of SOX6 and established mesothelioma markers produced sensitivities of 95% or greater. A combination of SOX6 positive\/claudin-4 negative staining was 95% to 100% specific for mesothelioma versus carcinoma with a sensitivity of 85%. SOX6 is a promising marker for the diagnosis of mesothelioma and potentially could be combined with other mesothelial markers or a broad-spectrum carcinoma marker to reach an accurate diagnosis with relatively few immunostains, The relatively low specificity and difficulty of interpreting DAB2 staining limits its utility for mesothelioma diagnosis.<\/jats:p>","DOI":"10.1097\/pas.0000000000001712","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:01:12Z","timestamp":1617076872000},"page":"1245-1251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma"],"prefix":"10.1097","volume":"45","author":[{"given":"Julia R.","family":"Naso","sequence":"first","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital"},{"name":"Department of Pathology, University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana N.","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital"},{"name":"Department of Pathology, University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/PAS.0000000000001507","article-title":"SOX6 is a novel immunohistochemical marker for differential diagnosis of epithelioid mesothelioma from lung adenocarcinoma","volume":"44","author":"Kambara","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/PAS.0000000000000852","article-title":"Identification of DAB2 and intelectin-1 as novel positive immunohistochemical markers of epithelioid mesothelioma by transcriptome microarray analysis for its differentiation from pulmonary adenocarcinoma","volume":"41","author":"Kuraoka","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.canep.2013.05.002","article-title":"Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma","volume":"37","author":"Guo","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"R5-20250608","first-page":"1010428317705508","article-title":"The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/1078-0432.CCR-10-1155","article-title":"Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma","volume":"17","author":"Qin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"145202","DOI":"10.1016\/j.gene.2020.145202","article-title":"The role of disabled-2 (Dab2) in diseases","volume":"769","author":"Ogbu","year":"2020","journal-title":"Gene"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2020.04.005","article-title":"Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4","volume":"100","author":"Naso","year":"2020","journal-title":"Hum Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/PAS.0000000000001469","article-title":"HEG1 is a highly specific and sensitive marker of epithelioid malignant mesothelioma","volume":"44","author":"Naso","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAI.0b013e31829b6fbd","article-title":"Value of calretinin immunostaining in diagnostic pathology: a review and update","volume":"22","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci Rep"},{"key":"R14-20250608","article-title":"HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion","author":"Hiroshima","year":"2020","journal-title":"Diagn Cytopathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:06:19Z","timestamp":1749416779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001712","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}